HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CTFA announces global forum

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics, Toiletry and Fragrance Association signs agreement Feb. 27 to create a forum on global harmonization of regulations for cosmetics and personal care products. CTFA and its co-signers - COLIPA in Europe, CCTFA in Canada, and JCIA in Japan - have formally proposed the forum to the regulatory bodies within their respective governments. The forum will pave the way toward international alignment of cosmetics regulations; similar to the harmonization afforded other products such as drugs and medical devices. "We've had informal discussions with regulators in the United States, and I know our counterparts in other countries have done the same," CTFA Public Affairs Committee member Francine Gingras, director of external relations for Procter & Gamble Beauty, said during CTFA's annual meeting in Boca Raton, Fla. "We are hopeful that we will have good feedback soon from our regulators to this proposal and that this initiative will get underway in the coming year." The agreement is part of CTFA's strategy to support the global market for cosmetics and personal care products (1"The Rose Sheet" Jan. 1, 2007, p. 3). Over the last year, CTFA has worked on consumer protection, trade and industry growth issues in countries such as China, Japan and Russia...

You may also be interested in...



CTFA Prioritizes Globalization, FDA Funding Among Goals For 2007

The Cosmetic, Toiletry & Fragrance Association is launching an "ambitious" agenda for 2007, with global harmonization, FDA funding and member education listed as top priorities for the new year

QUOTED. 11 May 2021. Phil Brown.

The MHRA is in listening mode as it gathers feedback to shape the UKCA marking for medical devices. See what Phil Brown, regulatory director of the Association of British HealthTech Industries, said about it here.

Fixed Combinations Of ‘Old Antibiotic’ Plus New Moiety Eligible For NCE Exclusivity, US FDA Says

A 2008 law that limited exclusivity for certain antibiotics to three years does not apply to Allergan’s Avycaz, which combines an approved old antibiotic active moiety and a new active moiety, CDER exclusivity board concludes.

UsernamePublicRestriction

Register

RS014567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel